Opportunity
DIBBS #SPE2DP-26-T-3264
DLA Solicitation for Hydroxyzine Hydrochloride Tablets, 25 mg, 100-count
Posted
May 06, 2026
Respond By
May 11, 2026
Identifier
SPE2DP-26-T-3264
NAICS
325412
This opportunity involves the Defense Logistics Agency (DLA) soliciting Hydroxyzine Hydrochloride Tablets for military medical supply: - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharmacy FSA - Contracting office: DLA Troop Support, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. (NDC00093-5061-01) - KVK-TECH INC (NDC10702-0011-01) - Vendors: Only the above OEMs are approved sources - Products/Services Requested: - Hydroxyzine Hydrochloride Tablets, USP, 25 mg, 100 tablets per bottle - NSN: 6505-01-530-3334 / Part Number: 6505015303334 - Quantity: 1 bottle - Packaging and marking per MIL-STD-2073-1E and Medical Marking Standard No. 1 - Shelf life: 36 months; storage at 20 to 25°C (68 to 77°F) - Unique or Notable Requirements: - Strict packaging, marking, and hazardous material labeling - Compliance with NIST SP 800-171 cybersecurity assessments - Prohibition on covered defense telecommunications equipment - Delivery/Place of Performance: - Delivery required within 20 days to Fort Campbell, KY (BLDG 5505A Wickham Ave, 42223-5000) - No additional administrative or procedural requirements specified
Description
HYDROXYZINE HYDROCH (QTY: 1, NSN: 6505-01-530-3334, Purchase Request: 7016620697) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-5061-01, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 57JV3, Part No: NDC10702-0011-01, Company: KVK-TECH INC